发明授权
- 专利标题： Apoptosis signal-regulating kinase inhibitor
- 专利标题（中）： 细胞凋亡信号调节激酶抑制剂
-
申请号： US13748901申请日： 2013-01-24
-
公开(公告)号： US08742126B2公开(公告)日： 2014-06-03
- 发明人: Gregory Notte
- 申请人： Gilead Sciences, Inc.
- 申请人地址： US CA Foster City
- 专利权人： Gilead Sciences, Inc.
- 当前专利权人： Gilead Sciences, Inc.
- 当前专利权人地址： US CA Foster City
- 代理机构： Gilead Sciences, Inc.
- 代理商 Yu-Ming Dammann
- 主分类号： C07D213/56
- IPC分类号： C07D213/56
摘要：
The present invention relates to a compound of formula (I): The compound has apoptosis signal-regulating kinase (“ASK1”) inhibitory activity, and is thus useful in the treatment of diseases such as kidney disease, diabetic nephropathy and kidney fibrosis.
公开/授权文献
- US20130197037A1 APOPTOSIS SIGNAL-REGULATING KINASE INHIBITOR 公开/授权日：2013-08-01
信息查询
